Form 8-K - Current report:
SEC Accession No. 0000947871-23-000080
Filing Date
2023-01-23
Accepted
2023-01-23 16:13:30
Documents
14
Period of Report
2023-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ss1693564_8k.htm   iXBRL 8-K 30087
2 PRESS RELEASE ss1693564_ex9901.htm EX-99.1 8595
3 GRAPHIC image_001.jpg GRAPHIC 2086
  Complete submission text file 0000947871-23-000080.txt   219776

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cvs-20230118.xsd EX-101.SCH 3197
5 XBRL LABEL FILE cvs-20230118_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cvs-20230118_pre.xml EX-101.PRE 22340
8 EXTRACTED XBRL INSTANCE DOCUMENT ss1693564_8k_htm.xml XML 3479
Mailing Address ONE CVS DR. WOONSOCKET RI 02895
Business Address ONE CVS DR. WOONSOCKET RI 02895 4017651500
CVS HEALTH Corp (Filer) CIK: 0000064803 (see all company filings)

EIN.: 050494040 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01011 | Film No.: 23544616
SIC: 5912 Retail-Drug Stores and Proprietary Stores